Lens, Glaucoma, and the Fundus Practice Test 2026 – Comprehensive All-in-One Guide to Exam Success!

Session length

1 / 20

Which dosing regimen is described for the affected eye in primary glaucoma?

Latanoprost Nightly And Monitor Yearly

Timolol Twice Daily

Dorzolamide 2% Once Daily

Alternating Drops Of Latanoprost And Dorzolamide Every 5 Minutes For 30 Minutes And Recheck IOP

Rapidly lowering intraocular pressure in the affected eye often needs a timed combination approach that uses two drugs with different mechanisms. Latanoprost lowers IOP by increasing uveoscleral outflow, while dorzolamide decreases aqueous humor production. Administering alternating drops every few minutes for about 30 minutes delivers a rapid, additive effect from both mechanisms, and then rechecking the IOP confirms how well the pressure has fallen and whether further treatment is needed. This approach is more effective for urgent or acute assessment than a single nightly drop or a single daily dose, which would not produce the same prompt reduction.

Next question

Find the option that is right for you!

All options are one-time payments.

$12.50

30 day premium pass

All the basics to get you started

  • Ad-free experience
  • View your previous attempt history
  • Mobile app access
  • In-depth explanations
  • 30 day premium pass access
👑$30.00 $87.50 usd

6 month DELUXE pass (most popular)

Everything with the 30 day premium pass FOR 6 MONTHS! & the ultimate digital PDF study guide (BONUS)

  • Everything included in the premium pass
  • $87.50 usd value for $30.00! You save $57.50!
  • + Access to the ultimate digital PDF study guide
  • + 6 months of premium pass access
  • + Priority support
$12.50 $18.99

Ultimate digital PDF study guide

For those that prefer a more traditional form of learning

  • Available for instant download
  • Available offline
  • Hundreds of practice multiple choice questions
  • Comprehensive content
  • Detailed explanations
Image Description
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy